Global Cell Signaling Market, Industry Growth, Analysis, and Forecast To 2022 – by Credence Research
According to the latest market report published by
Credence Research, Inc. “Cell Signaling Market -
Growth, Future Prospects and Competitive Analysis, 2017 -
2025” the global cell signaling market was valued at US$ 2.48 Bn in
2016, and is expected to reach US$ 4.35 Bn by 2025, expanding at a CAGR of
6.4% from 2017 to 2025.
Browse the full report Cell
Signaling Market - Growth, Future Prospects and Competitive Analysis, 2017 –
2025 at http://www.credenceresearch.com/report/cell-signaling-market
Market Insights
Cell signaling is a complex process
of communication, which governs basic activities of cells and coordinates cell
actions, it is a major field in modern medical practice and diagnosis. Factors
such as growing applicability of cell signaling in biotechnology, advancements
in cell-based research technology, growing biopharmaceutical industries and
wide availability advance cell signaling products are driving the growth of
cell signaling market globally. Cell signaling market is segmented on the basis
of product type such as antibodies, reagents, cellular assay kits and other
cellular signaling products. It is studied that currently, antibodies held
largest market share due to its wide applicability in molecular biology, and
its fundamental role in disease detection, structural analysis and mapping.
Cell signaling has wide application in medical and biotechnology however, for
the purpose of the study cell signaling market is segmented on the basis of
application such as drug discovery, ADME studies, predictive toxicology
studies, cancer research, stem cells research and other application.
Among the considered application, cancer research was major revenue generating
segment due to its increasing applicability in cancer research. There are
numerous cell signaling pathways exist such as AKT signaling pathway, AMPK
signaling pathway, ErbB/HER signaling pathway, hedgehog signaling pathway,
hippo signaling interactive pathway, JAK/STAT signaling pathway, notch
signaling pathway and other cell signaling pathways. Currently, PI3K/ AKT
signaling pathway has highest demand in market because AKT has been implicated
in diseases including cancer, diabetes and neuro-degeneration and thus widely
accepted in industries for basic research and drug development. It is studied
that, North America held a highest market share in global cell signaling market
because presence of large number of research institutes, growing life science
industries and higher investment in research and development activities. On the
anther hand Asia Pacific will show highest growth rate during forecast period
due to increasing R&D activities and growing partnership of key players
with local manufacturer would drive cell signaling market
growth.
Market Competition Assessment:
The cell signaling market is observed
to be highly competitive and comprises large number of players. However, the
market is currently dominated by few players such as Abcam plc., BD
Biosciences, Beckman Coulter, Inc. (a subsidiary of Danaher Corporation),
Bio-Rad Laboratories, Inc., BioVision, Inc., BPS Bioscience, Inc., Cell
Biolabs, Inc., Cell Signaling Technology, Inc., Cisbio Bioassays, Full Moon
BioSystems, Inc., Merck KGaA, Miltenyi Biotec, PerkinElmer Inc., Promega
Corporation, Qiagen N.V., Rockland Immunochemicals, Sino Biological, Inc.,
Thermo Fisher Scientific, Inc. and other.
Key Market Movements:
- Factors such as increase in
number of biotechnology and biopharmaceutical industries, technological
advancement in cell-based research technology and increasing applicability of
cell signaling in research and development are prime factors that driving the
growth of cell signaling market globally.
- However, ethical issues related to
embryonic cell signaling research and higher cost of cell signaling may
negatively impacting the growth of cell signaling market.
About Us:
Credence Research is a worldwide market research and
counseling firm that serves driving organizations, governments, non-legislative
associations, and not-for-benefits. We offer our customers some assistance with
making enduring enhancements to their execution and understand their most
imperative objectives. Over almost a century, we’ve manufactured a firm
extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more
than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are
in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East
and Africa.
Our firm is intended to work as one. We are a solitary
global research organization united by a solid arrangement of qualities,
concentrated on customer effect.
Latest Report -
What we do
We serve customers at each level of their organization, in
whatever limit we can be most helpful, whether as a trusted counsel to top
management or as a hands-on mentor for forefront representatives. For each
engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering
functional and persevering results, and preparing our customers to develop and
lead. We join forces with customers to place suggestions into practice. Our
research specialist work straightforwardly with customers over long stretches
to create workforce aptitudes, drive operational change, and apply new working
strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: +1-800-361-8290
Post a Comment